JDC-JSC’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$2.36M Sell
750
-34,320
-98% -$108M 11.34% 2
2020
Q2
$85K Buy
35,070
+30,170
+616% +$5.6M 0.14% 22
2020
Q1
$868K Sell
4,900
-11,428
-70% -$2.15M 3.78% 12
2019
Q4
$3.12M Buy
+16,328
New +$2.95M 19.86% 2

Other funds holding AGN

JDC-JSC's AGN Position: Q3 2020 in Review

JDC-JSC reduced its Allergan plc (AGN) stake by 98% in Q3 2020, selling an estimated $108M and leaving 750 shares worth $2.36M. The position accounts for 11.34% of the portfolio, ranked #2.

JDC-JSC first reported a position in AGN in Q4 2019 and has held it in 4 quarters since. The position peaked at $3.12M in Q4 2019. 3 funds tracked by Wall St. Rank hold AGN as of Q3 2020.

  • JDC-JSC held 750 shares of Allergan plc worth $2.36M as of Q3 2020.
  • JDC-JSC sold 34,320 Allergan plc shares in Q3 2020, an estimated $108M.
  • Allergan plc made up 11.34% of JDC-JSC's portfolio in Q3 2020, its #2 holding.
  • JDC-JSC first reported a position in Allergan plc in Q4 2019 and has held it in 4 quarters since.
  • JDC-JSC's Allergan plc position peaked at $3.12M in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Allergan plc as of Q3 2020.

Based on JDC-JSC's 13F filing for Q3 2020, filed 3 Nov 2020.